title: Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women.
abstract: OBJECTIVE
  Estrogen's effect on endothelial function in postmenopausal women with mild hypertension but no other cardiovascular risk factors remains unclear. This study investigated the effect of an acutely administered therapeutic/low dose of 17beta-estradiol on vasodilation in this patient population.
  
  
  METHODS
  Forearm blood flow (FBF) was measured in seven white, hypertensive (blood pressure 144 +/- 8/93 +/- 5 mmHg), postmenopausal (mean age: 54.4 +/- 5 years) women at baseline and during the intra-brachial infusion of increasing doses of acetylcholine (ACh; 0.75, 5, and 15 microg/100 mL tissue/min) and sodium nitroprusside (NP; 1, 2, and 4 microg/100 mL tissue/min). These measurements were obtained both before and after the sublingual administration of 17beta-estradiol. Eight normotensive women (blood pressure 115 +/- 8/76 +/- 5 mmHg) with otherwise similar characteristics served as controls (mean age: 55.8 +/- 5 years). Exclusion criteria included medications or any condition that could alter endothelial function.
  
  
  RESULTS
  Before estradiol administration, FBF values at baseline and after all doses of ACh and NP were similar between groups. Acutely administered 17beta-estradiol significantly improved the FBF response to ACh in both the normotensive (maximal response: 17.6 +/- 5 versus 22.5 +/- 7 mL/min/100 mL) and hypertensive (11 +/- 4 versus 16 +/- 6; 12 +/- 4 versus 17 +/- 5 and 14 +/- 3 versus 20 +/- 7 mL/min/100 mL) groups. It also altered the NP dose-response curve in the both groups.
  
  
  CONCLUSIONS
  17beta-estradiol improved vasodilatory responses in mildly hypertensive postmenopausal women without other risk factors for cardiovascular disease.
authors.affiliation: Heart Institute (InCor), Faculty of Medicine, University of São Paulo, São Paulo, Brazil. lima@silber.com.br
authors.forename: Sônia Maria Rolim Rosa
authors.initials: SM
authors.lastname: Lima
authors.forename: José Mendes
authors.initials: JM
authors.lastname: Aldrighi
authors.forename: Fernanda Marciano
authors.initials: FM
authors.lastname: Consolim-Colombo
authors.forename: Antonio de Pádua
authors.initials: Ade P
authors.lastname: Mansur
authors.forename: Marcelo Custódio
authors.initials: MC
authors.lastname: Rubira
authors.forename: Eduardo Moacyr
authors.initials: EM
authors.lastname: Krieger
authors.forename: José Antonio Franchini
authors.initials: JA
authors.lastname: Ramires
mesh_terms: D000286:Administration, Sublingual; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D016022:Case-Control Studies; D004730:Endothelium, Vascular / Q000187:drug effects; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D005542:Forearm / Q000098:blood supply; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D017698:Postmenopause; D011673:Pulsatile Flow; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D008055:Lipids; D004958:Estradiol